Find a Condition by Name
Adult Conditions
Pediatric Conditions
Health & Wellness Information
Treatment Programs
Coronavirus (COVID-19)
Find a Doctor by Name
Departments & Divisions
Locations & Maps
Forms & Medical Records
Travel & Lodging
Bill Pay
Insurance Information
Becoming a Patient
Patient Safety & Care
Health & Wellness Tips
Video Library
Infographics
Patient Education & Support
Professional Education - CME/CE
Morgridge Academy
Adult Clinical Trials
Pediatric Clinical Trials
See All Trials
Research Programs
Core Labs & Diagnostics
Tucker Medical Library
More
Tribute Gifts
Monthly Giving
Contact Development
Special Events
Legacy Gifts
Gifts of Assets
Our researchers are currently in need of adult and pediatric study participants to help us pursue better treatments and cures. Participants may receive medical evaluations and procedures, study medication, disease-related education and possible financial compensation for time, travel and participation.
Determine the efficacy and safety of lurbinectedin (a type of chemotherapy) when combined with atezolizumab (an immunotherapy treatment) as a maintenance treatment for those with ES-SCLC.
Researchers want to know if an investigational medication can reduce the number of exacerbations in people with chronic obstructive pulmonary disease (COPD).
The RESOLVE-Lung study is evaluating the safety and effectiveness of the investigational medicine namilumab for the treatment of pulmonary sarcoidosis.
Researchers are studying a new medication called PRA023 that has anti-inflammatory and antifibrotic properties to determine how well it works against systemic sclerosis (SSc) with interstitial lung disease (ILD).
To help better understand adrenal insufficiency (AI) and its progression, researchers have developed a new registry called MyAI.
The IPF COMFORT Study is a clinical research study in patients with coughing attributed to Idiopathic Pulmonary Fibrosis.
A clinical trial called ADVANCE CAPACITY seeks to understand if an investigational medication called ralinepag will help people with pulmonary arterial hypertension (PAH) improve their ability to exercise.
Researchers want to understand how the body of a person with active lung cancer responds to COVID-19, should they contract the virus.
Researchers want to know if inhaled nitric oxide delivered to the lungs will improve exercise tolerance and overall wellbeing of people with pulmonary fibrosis.
Researchers want to know if a small experimental device called Breathe Away is safe and effective. The device (the size of a large cell phone) gathers information from a pulse oximeter, which is worn on the ear of the participant.
Researchers want to learn if a blood test can be used to identify cancers in adults. Current or former smokers who have been diagnosed with cancer but haven’t started treatment are needed for this trial. Participants will receive a blood draw and review of their medical history with a research...
People with eosinophilic granulomatosis with polyangiitis (EGPA) are needed for the OCEAN clinical trial. The study compares two medications: mepolizumab (NUCALA), which is administered by an injection once a month, and depemokimab, an investigational medication that is injected twice a year.
U.S. military personnel and contractors who served in Iraq, Afghanistan and southwest Asia are contracting severe lung disease, and researchers want to know why.
Adults with Cystic Fibrosis who are unable to take CFTR modulators are being asked to participate in a clinical trial for an investigational gene therapy drug known as 4D-710.
Researchers are asking healthy adults, 25-35 years old, to join a five-year study exploring factors that may affect lung health with the goal of understanding lung disease.
Researchers want to determine if a possible new inhaled therapy, AR-501, is a safe and effective treatment for Pseudomonas infections in adults with cystic fibrosis.
If you are a pregnant with cystic fibrosis, consider participating in this trial to learn how pregnancy affects your health.
This exercise study is investigating how an already FDA approved drug for treatment of pulmonary vascular disease, sildenafil (Revatio ®), impacts exercise tolerance and capacity in people with cystic fibrosis (CF).
The purpose of this study is to collect data on what drives asthma in the body and how it reacts depending on the environment and treatment.
Researchers are developing a way to predict asthma attacks in adults with severe, difficult-to-treat asthma by collecting data while they sleep.
Researchers are trying to determine if an investigational medication called CMK389 improves lung function for people with chronic pulmonary sarcoidosis.
Can allergies be prevented in infants? Researchers want to know if keeping a baby’s skin healthy and hydrated with moisturizer will prevent the child from developing allergies such as food allergies. Learn how you and your child can help researchers.
National Jewish Health researchers are studying the antibody response to COVID-19 vaccines in people with chronic conditions.
Researchers are working to understand the different ways sarcoidosis, a disease that causes scarring in the lungs, develops.
Researchers want to better understand if the causes of asthma, eczema, food allergies, eosinophilic esophagitis and GERD can be determined at a cellular level.
Researchers want to find new measures of asthma control by tracking each participant’s asthma symptoms and response to omalizumab, while collecting data with a FitBit® and smartphone.
Can frequent video calls with a pharmacist via smart phone or computer help 14-30-year-olds take their prescribed asthma medications regularly and have fewer asthma symptoms?
Are biomarkers in the blood of patients with hypersensitivity pneumonitis (HP) predictive? Researchers understand if biomarkers can help doctors understand how quickly the disease will progress
Studies have shown that weight loss can improve heart function. Researchers want to see if a ketogenic diet is an effective treatment for heart failure with preserved ejection fraction.
Why do babies develop food allergies and eczema? Researchers are studying factors before birth and through age 3 that may influence the development of allergic conditions.
Researchers want to improve medical care for asthmatics with new mobile health technologies. Study participants will use at-home technologies to track and record health data and participate in surveys and questionnaires about their health.
Adults with cancer who are receiving immunotherapy are needed for a new research study to understand how immunotherapy changes the body’s immune response leading to skin reactions.
Researchers want to see if a new drug, alvelestat, improves the symptoms of lung disease caused by COPD due to alpha-1 antitrypsin deficiency (AATD), as well as symptoms of AATD.
Researchers are studying the differences in the skin and immune cells of people with food allergies and eczema, and those without.
Researchers want to know if a new medication, Saracatinib, is a more safe and effective treatment for Idiopathic Pulmonary Fibrosis (IPF) when compared to treatments that are currently available.
Adults ages 21 and older with chronic insomnia who have taken sleep medication for more than one year are needed for a clinical trial.
Researchers want to know what causes food allergies, eczema and wheezing in infants. If you’re pregnant, you may be able to help find the answer.
If you have uncontrolled asthma you may qualify for a study to help researchers understand how to treat different types of severe asthma using precision medicine.
Patients with medically inoperable stage I/IIA non-small cell lung cancer (NSCLC) who have not received prior anticancer therapy for lung cancer, may qualify for a clinical trial investigating if the combination of pembrolizumab (MK-3475) and Stereotactic Body Radiation Therapy (SBRT) may help...
If you’ve been exposed to silica dust, like stone and concrete, you may have developed a silica-related disease. National Jewish Health is creating a registry for silicosis and related diseases in order to better understand their risk factors and prevention.
National Jewish Health researchers want to understand what people with COPD know about their disease.
Our researchers are trying to determine if a study medication called omalizumab alone or combined with oral immunotherapy may help people with multiple food allergies.
Anyone with hypersensitivity pneumonitis may qualify for this observational study and help researchers find patterns for predicting ILD.
National Jewish Health researchers are trying to determine why people with atopic dermatitis or eczema are more susceptible to bacterial infections. Learn how you can participate in our research study.
Does your mind race at night when you're trying to sleep? Our researchers are studying how people with insomnia and obstructive sleep apnea can benefit from cognitive behavioral therapy, a goal-oriented type of treatment that aims to identify and change inaccurate or negative thinking patterns...
Our researchers are working to identify the clinical, physiologic, genetic and molecular characteristics of asthmatics.
By adding a new investigational Pulmonary Arterial Hypertension (PAH) medication to your current therapy, you could experience relaxed and widened artery walls.
By participating in our study, you can help forward research on lung disease. Our researchers are hoping to learn more about the blood cells involved in the development of scarring lung diseases and create new treatment therapies.
The purpose of this study is to learn more about lung disease found in contractors and U.S. military personnel serving in Iraq and Afghanistan after September 11, 2001.
Our researchers are trying to understand the connection, as well as how to prevent and treat lung disease in RA patients.
Our researchers are trying to understand how interstitial lung disease (ILD) develops in people with rheumatoid arthritis (RA), and how it may impact their quality of life.
The purpose of this study is to measure and accurately identify the presence and severity of gastroesphageal reflux disease (GERD), commonly called acid reflux, in idiopathic pulmonary fibrosis (IPF) patients using the Supraglottic Index (SGI).
Our researchers are studying the lungs of current and former smokers to understand how to improve the diagnosis and treatment of Chronic Obstructive Pulmonary Disease (COPD), a disease that is common among smokers. You do not need to have COPD to participate in this study.
If you are an adult with sarcoidosis who is not on immunosuppressive therapy, you may be able to help our researchers learn more about different types of sarcoidosis and how it develops.
Our researchers are studying lung diseases that develop from inhaling mineral dust over time. Although the cause of diseases such as "black lung" are known, it is not well understood why some people develop these diseases and others don't.
The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis.
Adults with cystic fibrosis (CF) are at a higher risk of developing colon cancer due to a mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) gene..